Searchable abstracts of presentations at key conferences in endocrinology

ea0033p29 | (1) | BSPED2013

Prevalence and screening of thyroid and coeliac disease in type 1 diabetes mellitus

Arkush Leo , Williams Emma , Hakeem Vaseem

Introduction: Children with type 1 diabetes mellitus are at increased risk of autoimmune thyroid and coeliac disease. Reported prevalence figures for thyroid and coeliac disease in this population has been reported in European studies as 3–8%1 and 1–10%2 respectively. Current NICE guidelines (June 2009) recommend screening for both conditions at diagnosis, and then screening annually for thyroid disease thereafter. We aimed to: i) estimate preva...

ea0044p23 | Adrenal and Steroids | SFEBES2016

The pharmacokinetic profile of prednisolone is not affected by ingestion of food – how should patients be advised?

Choudhury Sirazum M , Williams Emma L , Tan Tricia M , Meeran Karim

Background: Prednisolone is used for glucocorticoid replacement therapy in Adrenal Insufficiency. Package inserts indicate that prednisolone should be administered with or after food as there is a belief that prednisolone causes stomach ulcers. We have investigated the impact of various fasted and non-fasted states on its pharmacokinetic profile.Method: A healthy volunteer provided three 4 mg prednisolone profiles. The first was a fasted reference curve....

ea0044p26 | Adrenal and Steroids | SFEBES2016

Could modified release prednisone hold the key to closer reproduction of the glucocorticoid circadian rhythm in Adrenal Insufficiency?

Choudhury Sirazum M , Leckey Adam , Williams Emma L , Tan Tricia M , Meeran Karim

Background: The cortisol circadian rhythm has an early morning peak with an increase before awakening, and a second lunchtime peak. Using a UPLC-MS/MS technique to measure prednisolone, the active metabolite of prednisone, we investigated the suitability of modified release (MR) prednisone (Lodotra) as a replacement therapy.Method: Blood samples were taken at fixed time points after the administration of MR-prednisone. Concentrations of the active metabo...